Literature DB >> 8847086

Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis.

M Soto1, J M Requena, L Quijada, F Guzman, M E Patarroyo, C Alonso.   

Abstract

In the present work we show that a high percentage of the sera from dogs naturally affected with viscero-cutaneous leishmaniasis contain antibodies reacting with the Leishmania infantum P0 ribosomal protein. In order to map the antigenic determinants of the LiP0 protein during Leishmania-infection, the complete amino acid sequence of the protein was synthesized as overlapping 20-mer peptides. We have identified the sequence AAKEEPEESDEDDFGMG, located adjacent to the C-terminal end of the protein, as the major antigenic determinant. The anti-LiP0 antibodies present in the sera of the infected dogs do not cross-react with a relatively similar antigenic determinant of the LiP2 acidic proteins as an indication that the Leishmania P0 protein is an independent immunogenically functional antigen in the canine form of the infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847086     DOI: 10.1016/0165-2478(95)02436-0

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.

Authors:  Salvador Iborra; Javier Carrión; Charles Anderson; Carlos Alonso; David Sacks; Manuel Soto
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis.

Authors:  M Soto; J M Requena; L Quijada; C Alonso
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

3.  Specific serodiagnosis of human leishmaniasis with recombinant Leishmania P2 acidic ribosomal proteins.

Authors:  M Soto; J M Requena; L Quijada; C Alonso
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

4.  The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites.

Authors:  K Rajeshwari; Kalpesh Patel; Savithri Nambeesan; Monika Mehta; Alfica Sehgal; Tirtha Chakraborty; Shobhona Sharma
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice.

Authors:  Salvador Iborra; Manuel Soto; Javier Carrión; Ana Nieto; Edgar Fernández; Carlos Alonso; Jose M Requena
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers.

Authors:  S Iborra; D R Abánades; N Parody; J Carrión; R M Risueño; M A Pineda; P Bonay; C Alonso; M Soto
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

7.  Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters.

Authors:  Lais Pereira; Melissa Abbehusen; Clarissa Teixeira; Jurema Cunha; Ivan P Nascimento; Kyioshi Fukutani; Washington dos-Santos; Aldina Barral; Camila Indiani de Oliveira; Manoel Barral-Netto; Manoel Soto; Cláudia Ida Brodskyn
Journal:  PLoS Negl Trop Dis       Date:  2015-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.